Feature
The Post-Election Boardroom
By Alexandra R. Lajoux
Six scenarios that boards should consider to prepare for potential regulatory changes after the November US election.
Trending Oversight Topics
Governance Surveys
Center for Inclusive Governance
Feature
09/16/2024
Photo Credit: iStockphoto / Maisel
In 2007, Israeli national security officials told their American counterparts about a building being constructed at Al Kibar in Syria, Micah Zenko writes in his book, Red Team: How to Succeed by Thinking Like the Enemy. The Israelis feared that it was a nuclear reactor, similar to one developed by the North Koreans...
Jeff Kindler, CEO of Centrexion Corp., a privately held biotherapeutics company, previously served as chair and CEO of Pfizer. He is a senior advisor for Blackstone, a member of the boards of several public and private organizations, and a principal in and advisor to a number of health-care firms and sponsors.
Thank you for your interest in this page.
Explore All Directorship Issues